Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/87907
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Gold, L. | - |
dc.contributor.author | Eaton, B. | - |
dc.contributor.author | Smith, D. | - |
dc.contributor.author | Wecker, M. | - |
dc.contributor.author | Jensen, K. | - |
dc.contributor.other | Swanson & Bratschun LLC, | - |
dc.date.issued | 1998 | - |
dc.identifier.uri | http://hdl.handle.net/2440/87907 | - |
dc.description | Publication number US5763595 A Publication type Grant Application number US 08/463,093 Publication date Jun 9, 1998 Filing date Jun 5, 1995 Priority date Jun 11, 1990 | - |
dc.description.abstract | This application provides methods for identifying nucleic acid ligands capable of covalently interacting with targets of interest. The nucleic acids can be associated with various functional units. The method also allows for the identification of nucleic acids that have facilitating activities as measured by their ability to facilitate formation of a covalent bond between the nucleic acid, including its associated functional unit, and its target. | - |
dc.description.statementofresponsibility | Inventors: Larry Gold, Bruce Eaton, Drew Smith, Matthew Wecker, Kirk Jensen. Assignee: NeXstar Pharmaceuticals, Inc. Agents: Swanson & Bratschun LLC | - |
dc.language.iso | en | - |
dc.title | Systematic evolution of ligands by exponential enrichment: Chemi-SELEX | - |
dc.type | Patent | - |
dc.contributor.assignee | NeXstar Pharmaceuticals, Inc. | - |
dc.identifier.patent | US5763595 | - |
pubs.publication-status | Published | - |
dc.identifier.orcid | Jensen, K. [0000-0002-2084-1734] | - |
Appears in Collections: | Aurora harvest 2 Molecular and Biomedical Science publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.